24 Mar 2020

Biotech listings in Hong Kong

Linkedin

Biotech and life sciences

Global economic development, population growth, ageing society and technological advances have contributed to the considerable growth in the biotech industry in recent years.

Major global stock markets have in recent years developed new listing rules specifically for the biotech sector to facilitate effective allocation of venture capital and private equity funds, completing the "input-output" cycle of capital deployment and optimising resources allocation.

On 30 April 2018, the biggest change to Hong Kong Listing Rules for 25 years took place as new Listing Rules came into effect to include a new listing chapter (Chapter 18A) to welcome pre-revenue biotech companies.

Click here to read the full article.

Linkedin

KEY CONTACT

Voon Keat Lai

Voon Keat Lai
Managing partner

T:  +852 2533 2790 M:  Email Voon | Vcard Office:  Beijing, Hong Kong, Shanghai

Jane Ng

Jane Ng
Partner

T:  +852 2533 2828 M:  Email Jane | Vcard Office:  Hong Kong

Michael Mok

Michael Mok
Professional support lawyer

T:  +852 3166 6910 M:  Email Michael | Vcard Office:  Hong Kong

  • Related Sectors
  • Related Locations